Loading company…
Yingke Biopharmaceutical researches and develops injectable nutrition, anesthesia, and oncology medicines.
Yingke Biopharmaceutical develops pharmaceuticals including parenteral nutrition drugs, anesthesia and oncology treatments, concentrated amino acids, and diagnostic kits. Its products include propofol injections and mushroom polysaccharide injection. Founded in 2011, it is based in Taizhou, China. In June 2023, it raised over CNY 300 million in Series B funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in